Validation of Next Generation Sequencing-Based Clonality Assays for Diagnosis and Minimal Residual Disease Tracking in Lymphoid Malignancies

被引：0
|
作者：
Wu, Haiyan [1 ]
Li, Feng [1 ]
Cai, Jiacheng [1 ]
Zhang, Ke [1 ]
Zheng, Xin [1 ]
Yao, Jicheng [1 ]
Wang, Weifeng [1 ]
Wang, Kai [1 ]
机构：
[1] OrigiMed Co Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-150151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Clinical Utilization of Next-Generation Sequencing-Based Clonality Assays for Immunoglobulin Heavy Chain in Evaluating Suspected B-Cell Proliferation
    Katerji, Hani
    Katerji, Roula
    Campbell, Andrew
    Rothberg, Paul
    Ding, Yi
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 : S134 - S135
  • [42] IGH-FR1 and Leader Analysis By Next Generation Sequencing for the Detection of Clonality and Somatic Hypermutation in Lymphoid Malignancies
    Piccaluga, Pier Paolo
    Gazzola, Anna
    Huang, Ying
    Panganiban, Jeff
    Hutt, Kasey
    Klass, Michael
    BLOOD, 2015, 126 (23)
  • [43] VALIDATION AND IMPLEMENTATION OF NEXT GENERATION SEQUENCING-BASED HLA TYPING FOR CLINICAL DIAGNOSTICS
    de Hoop, Talitha A.
    Kooter, Raul
    de Graaff, Anna C.
    Rozemuller, Erik H.
    Penning, Maarten
    Spierings, Eric
    TISSUE ANTIGENS, 2014, 84 (01): : 12 - 12
  • [44] Next generation sequencing based approach for monitoring of minimal residual disease in acute lymphoblastic leukemia
    Komkov, A.
    Minervina, A.
    Pogorelyy, M.
    Zvyagin, I.
    Panferova, A.
    Olshanskaya, Y.
    Chudakov, D.
    Maschan, M.
    Mamedov, I.
    Lebedev, Y.
    FEBS JOURNAL, 2016, 283 : 376 - 376
  • [45] Read the clonotype: Next-generation sequencing-based lymphocyte clonality analysis and perspectives for application in pathology
    Groenen, Patricia J. T. A.
    van den Brand, Michiel
    Kroeze, Leonie I.
    Amir, Avital L.
    Hebeda, Konnie M.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [46] Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Multiple Myeloma
    Takamatsu, Hiroyuki
    Murata, Ryoichi
    Zheng, Jianbiao
    Moorhead, Martin
    Takezako, Naoki
    Ito, Shigeki
    Miyamoto, Toshihiro
    Yokoyama, Kenji
    Matsue, Kosei
    Sato, Tsutomu
    Kurokawa, Toshiro
    Yagi, Hideo
    Terasaki, Yasushi
    Ohata, Kinya
    Yoshida, Takashi
    Faham, Malek
    Nakao, Shinji
    BLOOD, 2014, 124 (21)
  • [47] Monitoring minimal residual disease in the bone marrow using next generation sequencing
    Rustad, Even H.
    Boyle, Eileen M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (01)
  • [48] Standardized minimal residual disease detection by next generation sequencing in multiple myeloma
    Yao, Qiumei
    Bai, Yinlei
    Orfao, Alberto
    Chim, James
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E175 - E175
  • [49] The utility of next generation sequencing-based minimal residual disease monitoring in a post-myeloproliferative neoplasm acute myeloid leukemia patient: a case report
    Choi, Yu Jeong
    Kook, Hye Won
    Lee, Seung-Tae
    Song, Jaewoo
    Choi, Jong Rak
    Cheong, June-Won
    Shin, Saeam
    LEUKEMIA & LYMPHOMA, 2024, 65 (13) : 2040 - 2043
  • [50] Identification Of Actionable Genomic Alterations In Hematologic Malignancies By a Clinical Next Generation Sequencing-Based Assay
    Lipson, Doron
    Nahas, Michelle K.
    Otto, Geoff A.
    Yelensky, Roman
    Abdel-Wahab, Omar
    Wang, Kai
    He, Jie
    Intlekofer, Andrew M.
    Rampal, Raajit K.
    Brennan, Timothy A.
    Knapp, Kristina M.
    Brennan, Kristina W.
    Young, Geneva
    Donahue, Amy L.
    Sanford, Eric M.
    Greenbowe, Joel R.
    Frampton, Garrett M.
    Fichtenholtz, Alex
    Young, Lauren E.
    Erlich, Rachel L.
    Parker, Alex
    Klimstra, David
    Dogan, Ahmet
    Ross, Jeffrey S.
    Armstrong, Scott A.
    Stephens, Philip J.
    van den Brink, Marcel R. M.
    Miller, Vincent A.
    Levine, Ross L.
    BLOOD, 2013, 122 (21)
12345